Pharmaceutical Technology

MARCH 31, 2023

This also demonstrates our confidence in the investment climate in Kenya and the importance of utilising mRNA technology to build resilience in healthcare security in Africa.” Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Manufacturing 264

Manufacturing Gene Therapy Gene Genetics 264

Pharmaceutical Technology

MAY 18, 2023

Forbion European Acquisition has entered a definitive business combination agreement with biotechnology company enGene to create a combined biotechnology company to develop next-generation non-viral, locally administered gene therapies. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Gene Therapy 130

Gene Therapy Gene In-Vivo Life Science 130

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Neuroendocrine Tumors have a 74% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Head And Neck Cancer Squamous Cell Carcinoma have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Pharmaceutical Technology

FEBRUARY 10, 2023

On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Gene Therapy 263

Gene Therapy Marketing Gene Drugs 263

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors. However, there is still some use of remote patient monitoring technologies.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Dermatology 130

Pharmaceutical Technology

APRIL 19, 2023

While Bayer’s commitment to women’s health has resulted in limited success and has fallen short of investor expectations, the pharmaceutical giant is still committed to pursuing some of its clinical-stage products, including elinzanetant and its two Phase I assets targeting endometriosis, BAY2328065 and BAY2395840, says GlobalData.

Gene Therapy 130

Gene Therapy Hormones Production Sales 130

Pharmaceutical Technology

DECEMBER 15, 2022

HFC products must be administered intravenously in a healthcare setting and carry risks of thrombosis. However, the large size of the fibrinogen molecule has prevented the production of a recombinant fibrinogen protein and will delay potential development of gene therapies in the future.

Marketing 130

Marketing Production Genotype Development 130

Drug Discovery World

DECEMBER 21, 2023

Analysts GlobalData predict that the total sales of IBD drugs will reach approximately $10.2 Innovative clinical options for IBD Research shows that PHD 1/2 plays a critical role in regulating the stability and transcriptional activity of the hypoxia-inducible factor-1α (HIF-1α), which drives the expression of barrier protective genes.

Trials 52

Trials Clinical Trials Clinical Trials Medicine 52

Pharmaceutical Technology

NOVEMBER 23, 2022

One of the primary focus areas includes the continued commercialisation of cutting-edge cell and gene therapies, which involve the modification of cells from patients or donors to produce highly personalised therapies and regenerative medicines.

Marketing 130

Marketing Gene Therapy Life Science Manufacturing 130

Pharmaceutical Technology

JUNE 21, 2023

CSL announced the first patient with haemophilia B has been treated with its recently approved gene therapy Hemgenix (etranacogene dezaparvovec). Hemgenix is the first and only gene therapy approved for haemophilia B. per dose, it is the most expensive single-use gene therapy in the US.

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

Pharmaceutical Technology

OCTOBER 26, 2022

The biotherapeutics market is rapidly growing, with 2021 seeing the highest-ever cell and gene therapy approval number. Gene therapy uses DNA to manipulate cells and correct defective genes, whereas cell therapy is the infusion or transplantation of cells into a patient. The future of cell and gene therapies.

Gene Therapy 130

Gene Therapy Gene Marketing Manufacturing 130

Pharmaceutical Technology

JULY 29, 2022

Mikael Dolsten, Pfizer’s chief scientific officer, told Goldman Sachs’ 43rd Annual Global Healthcare Conference on 15 June: “The upgraded vaccine is about two weeks from now. Pfizer completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted bivalent Covid-19 vaccine candidate, based on the BA.1

Manufacturing 130

Manufacturing Vaccination Vaccine Packaging 130

Pharmaceutical Technology

JUNE 4, 2023

Innovation S-curve for the pharmaceutical industry Transcription factors for AAV is a key innovation area in pharmaceutical Adeno-associated virus (AAV) vectors are widely used for gene therapy. There are two main genes in the AAV genome, rep and cap, which encode nine different proteins.

Gene 262

Gene Gene Therapy Genetics DNA 262

XTalks

MAY 2, 2024

Morgan Healthcare Conference in January, James Mock, chief financial officer at Moderna, said the company is confident it can make a dent in the market due to the vaccine’s efficacy and favorable safety and tolerability. Morgan Healthcare Conference in January, BridgeBio CEO Neil Kumar was confident about acoramidis’ faring in the market.

Drugs 52

Drugs FDA Approval Sales Vaccination 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

The company told GlobalData PharmSource: “The biosimilar facilities in Austria and Slovenia would continue to manufacture biosimilars for Sandoz under a contractual agreement with Novartis. stake in their consumer healthcare joint venture for $13bn.

Manufacturing 162

Manufacturing Drugs Branding Sales 162

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. GlobalData is the parent company of Pharmaceutical Technology.

Vaccination 162

Vaccination Vaccine Antibody FDA Approval 162

Pharmaceutical Technology

MARCH 20, 2023

Source: GlobalData. In the fourth quarter of 2022, the most recent period for which data is available, GlobalData estimates suggest the value of venture capital investment in pharmaceutical firms worldwide was $7.8 Research – and money – going into even more advanced gene therapies is ramping up. Source: GlobalData.

Gene Therapy 225

Gene Therapy Genome Genomics Gene 225

Pharmaceutical Technology

APRIL 24, 2023

Having steadily risen over the last two decades, 2020 saw more approvals for biopharmaceuticals, often termed as biologics, than any other year in the last decade, according to GlobalData analysis. Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

MARCH 29, 2023

Pharmaron is receiving a £151 million investment in capital to support the growth of operations in Liverpool, quadrupling production capacity for gene therapy and vaccine components. On March 10, the National Health Service provided a grant for building a new cell and gene therapy manufacturing facility in Bristol.

Life Science 276

Life Science Manufacturing Gene Therapy Medicine 276

Pharmaceutical Technology

APRIL 11, 2023

The treatment will now be available to children with two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF is a rare disease caused by a defect in the CTFR gene, causing mucus to build in internal organs and subsequent inflammation and digestive problems.

Medicine 246

Medicine Gene Trials Marketing 246

Pharmaceutical Technology

MARCH 6, 2023

At Kaeberlein’s lab, studies track effects on aging through an approach that is largely focused on genetics, modifying different genes to figure out what affects healthspan and lifespan. This regulatory issue coupled with others has hindered the clinical development of drugs in the field. Evaluate the effects of COVID-19 on the sector.

Drugs 363

Drugs Regulation Clinical Trials Clinical Trials 363

Pharmaceutical Technology

FEBRUARY 20, 2023

A 2022 report published by GlobalData found that in analysis of 12,698 clinical trials initiated over nine and a half years to June 2022 racial minority representation in pivotal studies is extremely low, accounting for 23.9% This may sound obvious, but it is still a major hurdle in drug development. of the clinical trial population globally.

Research 130

Research Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

MAY 9, 2023

According to GlobalData analysis, the number of clinical trials with a decentralised and virtual component increased by 50% between 2020 and 2021, and this trend is here to stay. GlobalData analysis shows that Asia-Pacific is one of the fastest-growing geographies for clinical research, accounting for more than 50% of global trials in 2022.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130